Science & Nature · 2

What did Casgevy become in 2023-2024, marking a historic medical milestone?

Answer

First CRISPR-based gene therapy approved for human use

Casgevy became the first-ever CRISPR-based therapy approved for human use, gaining UK approval in November 2023 and FDA approval in December 2023 for treating sickle cell disease. During 2024, it received approval across the UK, US, EU, Bahrain, Saudi Arabia, and Canada. This landmark achievement represents the culmination of decades of gene-editing research and opens doors to treating genetic diseases at their source.

💡 Did you know?

Casgevy uses CRISPR-Cas9 to edit patients' own blood cells, eliminating the genetic cause of sickle cell disease rather than just treating symptoms.

Other options people guess

  • First AI-designed antibiotic
  • First personalized cancer vaccine
  • First synthetic organ transplant

Topics

  • genetics
  • CRISPR
  • gene-therapy

Know your science & nature trivia?

Play a free Science & Nature quiz and see how many you get right — no signup needed to start.

More Science & Nature facts